Mettler-Toledo International Stock News

Wall Street sees the Bozeman, Mont., company posting good results for the December-ended fiscal first quarter.

Mettler-Toledo International is an interesting company, but not one that comes attractively priced. Due to mixed financial results, MTD is now even more expensive, prompting a downgrade to 'sell'. Revenue and profit inconsistencies, especially in China, and high operating costs overshadow minor improvements in gross profit margins.

COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) announced it will release its fourth quarter 2024 financial results after the market close on Thursday, February 6, 2025. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on t...

Investors are always scanning the horizon for the next big thing in stocks. For the past few years, it's clear that Nvidia (NASDAQ: NVDA) has been the key winner that's driven most index (and portfolio) returns.

COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) today announced it will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 14, 2025 at 3:45 p.m. Pacific Time. A live webcast of the presentation will be available on the Company's investor relations website at investors.mt.com. METTLER TOLEDO (NYSE: MTD) is a leadin...

Mettler-Toledo's Q3 sales were up 1% year-over-year and behind expectations. Management projects 2025 sales growth of 3% and my numbers get to  ~$1 billion in NOPAT by this year. China and ex-US sales have been a drag on performance and this must be considered going forward.

Mettler-Toledo International Inc. (NYSE:MTD ) Q3 2024 Earnings Conference Call November 8, 2024 8:30 AM ET Company Participants Adam Uhlman - Head of Investor Relations Patrick Kaltenbach - Chief Executive Officer Shawn Vadala - Chief Financial Officer Conference Call Participants Vijay Kumar - Evercore ISI Matt Sykes - Goldman Sachs Dan Arias - Stifel Dan Leonard - UBS Jack Meehan - Nephron Re...

Medical equipment maker Mettler-Toledo International beat third-quarter profit estimates on Thursday, helped by increased demand for its laboratory instruments used in drug development and research.